The UK government has confirmed that it will continue to accept CE marked medical devices on a long-term basis, meaning ...
Delegates at this year’s Vascular Access Society of Britain and Ireland (VASBI) annual scientific meeting (24–25 September, ...
Haemonetics has announced US Food and Drug Administration (FDA) approval of the PerQseal Elite vascular closure system for large-bore arterial procedures. According to the company, the approval ...
A subset analysis of the landmark STORM-PE randomised controlled trial (RCT) demonstrated a significant correlation between real-world, daily step-based activity as captured on a consumer wearable ...
526 Fulham Road, Fulham, London, SW6 5NR TEL:+44 (0)20 7736 8788 ...
Stefano Barco (University Hospital Zurich, Zurich, Switzerland) talks through the superior one-year outcome data from the SirPAD randomised controlled trial (RCT) comparing the MagicTouch PTA ...
Nectero Medical recently announced that the American Medical Association’s CPT editorial panel has approved two category III CPT codes applicable to the Nectero endovascular aneurysm stabilisation ...
“The future of vascular surgery is incredibly bright,” Daniel Clair (Vanderbilt University Medical Center [VUMC], Nashville, USA) opines in this interview with Vascular News on his career in the field ...
9th EndoVascular resuscitation and Trauma Management (EVTM) Symposium 11th March 2024 ...
Human lung tissue with pulmonary embolism under a microscope. Credit: ChrWeiss – stock.adobe.com. Inquis Medical has announced the US commercial launch of its latest Aventus catheter, which is ...
Laminate Medical Technologies has announced their flagship device, the VasQ External Vascular Support, has been cleared by the US Food and Drug Administration (FDA) for use to create arteriovenous ...
Frank Veith (Case Western Reserve University, Cleveland, USA; New York University Medical Center, New York, USA), chairman of the VEITHsymposium, has announced that Gustavo Oderich (Baylor College of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results